Modulating the Immune Response to SARS-CoV-2 by Different Nanocarriers Delivering an mRNA Expressing Trimeric RBD of the Spike Protein: COVARNA Consortium

Researchers evaluated the immunogenicity and efficacy of different rationally designed lipid and polymeric-based nanoparticle prototypes against SARS-CoV-2 infection.